InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by VINCENT RICHARD G, Chief Financial Officer. Officer active across 1 company, notably Oncternal Therapeutics, Inc.. In total, 5 filings have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €16k. Activity tracked since 3 January 2022. The latest transaction was filed on 24 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations5 total
3 shares@ US$1.450.0% of flowCommon StockSEC:0001209191-22-021302:0
Ideal exit: 19 Dec 2022 (T+270)
5,000 shares@ US$1.8050.0% of flowCommon StockSEC:0001209191-22-005559:0
Ideal exit: 24 Oct 2022 (T+270)
5,000 shares@ US$1.80100.0% of flowCommon StockSEC:0001209191-22-005559
Ideal exit: 24 Oct 2022 (T+270)
29,867 shares0Common StockSEC:0001209191-22-001971
29,867 shares0Common StockSEC:0001209191-22-001971:0
5 of 5 declarations
About VINCENT RICHARD G
Richard G. Vincent is Chief Financial Officer at Oncternal Therapeutics, Inc. He manages the company's finances, overseeing financial reporting and budgeting strategy. His role is crucial for ensuring financial transparency and regulatory compliance at Oncternal Therapeutics.
